May 15 2018
Auris announced its collaboration with NeuWave Medical, a subsidiary of Ethicon, Inc. and part of the Johnson & Johnson Medical Devices Companies this week. The goal is to enable robotically assisted bronchoscopic ablation of lesions in the lung. This cooperative development and commercialization agreement calls for a co-development of integrated systems for robotic control, navigation and application of microwave ablation delivered via bronchoscopes.
Excerpts from the press release:
“From the beginning, our vision has been to create a platform capable of enabling advanced diagnosis and therapy for a spectrum of disease, using the least-invasive approach,” said Frederic Moll, M.D., co-founder and CEO of Auris Health."
“For those treating people with suspicious nodules in the lung, the holy grail is to one day be able to detect and treat the disease in a single procedure,” said Kazuhiro Yasufuku, MD, Associate Professor of Surgery at the University of Toronto. “When this option becomes a reality, we may see many patients seek early screening and minimally invasive treatment.”Read the Full Press Release